Back
NovoCure 10K Form
Sell
35
NVCR
NovoCure
Last Price:
12.36
Seasonality Move:
12.01%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-10-26 | 10Q | NVCR/NovoCure Quarterly |
| 2023-07-27 | 10Q | NVCR/NovoCure Quarterly |
| 2023-05-04 | 10Q | NVCR/NovoCure Quarterly |
| 2022-10-27 | 10Q | NVCR/NovoCure Quarterly |
| 2022-07-28 | 10Q | NVCR/NovoCure Quarterly |
| 2022-04-28 | 10Q | NVCR/NovoCure Quarterly |
Receive NVCR News And Ratings
See the #1 stock for the next 7 days that we like better than NVCR
NVCR Financial Statistics
Sales & Book Value
| Annual Sales: | $509.34M |
|---|---|
| Cash Flow: | $-21.38M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.39 |
| Price / Book: | 3.58 |
Profitability
| EPS (TTM): | -1.95000 |
|---|---|
| Net Income (TTM): | $-207.04M |
| Gross Margin: | $381.06M |
| Return on Equity: | -50.62% |
| Return on Assets: | -17.8% |
NovoCure Earnings Forecast
Key NovoCure Financial Ratios
- The Gross Profit Margin over the past 11 years for NVCR is 74.81%.
- The Selling, General & Administrative Expenses for NVCR have been equal to 76.74% of Gross Profit Margin.
- The Research & Development expenses have been 43.79% of Revenue.
- The Interest Expense is -1.60% of Operating Income.
- The Net Earning history of NVCR is -40.65% of Total Revenues.
- Per Share Earnings over the last 11 years have been positive in 5 years.
NovoCure Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | NVCR |
| CUSIP: | G6674U |
| Website: | novocure.com |
Debt
| Debt-to-Equity Ratio: | 1.57 |
|---|---|
| Current Ratio: | 5.78 |
| Quick Ratio: | 5.51 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |